Showing results (211-220 of 269) with videos related to
Sort By:
Pageof 27
Breast Cancer Research and Treatment|May 28, 2017
Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat modelChiaming Fan, Kristen R Georgiou, Howard A Morris, et al.International Journal of Impotence Research|August 30, 2001
Evaluation of oral ro70-0004/003, an alpha1A-adrenoceptor antagonist, in the treatment of male erectile dysfunctionA Choppin, D R Blue, S S Hegde, et al.Toxicology and Applied Pharmacology|June 28, 2005
Polymorphic variations in the expression of the chemical detoxifying UDP glucuronosyltransferasesP I Mackenzie, P A Gregory, R H Lewinsky, et al.Science Advances|August 6, 2025
Anthropogenic warming drives earlier wildfire season onset in CaliforniaGavin D Madakumbura, Max A Moritz, Karen A McKinnon, et al.Physiological Reviews|February 7, 2019
The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel ParadigmsRobyn Meech, Dong Gui Hu, Ross A McKinnon, et al.Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Association between Patient-Reported Outcomes and Survival in Patients with Advanced Urothelial Carcinoma Treated with AtezolizumabEugene Tan, Ahmad Y Abuhelwa, Sarah Badaoui, et al.Critical Reviews in Oncology/Hematology|February 29, 2020
A literature review of treatment-specific clinical prediction models in patients with breast cancerNatansh D Modi, Michael J Sorich, Andrew Rowland, et al.Cancer Chemotherapy and Pharmacology|February 28, 2022
A clinical scoring tool validated with machine learning for predicting severe hand-foot syndrome from sorafenib in hepatocellular carcinomaAhmad Y Abuhelwa, Sarah Badaoui, Hoi-Yee Yuen, et al.Biochemical Pharmacology|January 10, 2017
Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemiaJohn O Miners, Nuy Chau, Andrew Rowland, et al.Breast (Edinburgh, Scotland)|April 27, 2021
Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclibNatansh D Modi, Ahmad Y Abuhelwa, Sarah Badaoui, et al.Pageof 27